Boston Scientific Corp (NYSE:BSX)

27.20
Delayed Data
As of Feb 16
 +0.11 / +0.41%
Today’s Change
23.29
Today|||52-Week Range
29.93
+9.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-119.0M-239.0M347.0M--
 
 
 
 
Depreciation725.0M769.0M815.0M--
 
 
 
 
Total Other Cash Flow98.0M322.0M-186.0M--
 
 
 
 
Funds From Operations307.0M320.0M976.0M--
 
 
 
 
Funds From/For Other Operating Expenses-962.0M-280.0M4.0M--
 
 
 
 
Net Cash Flow - Operating Activities1.3B600.0M972.0M--
 
 
 
 
 
InvestingIncrease In Investments-26.0M-266.0M-132.0M--
 
 
 
 
Decrease In Investments14.0M61.0M0.00--
 
 
 
Capital Expenditures-259.0M-247.0M-376.0M--
 
 
 
 
Fixed Asset Disposal12.0M0.0029.0M--
 
 
 
Net Assets From Acquisitions -486.0M-1.7B-408.0M--
 
 
 
 
Net Cash Flow Investing-745.0M-2.2B-887.0M--
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings810.0M3.1B630.0M--
 
 
 
 
Long Term Debt Reduction-810.0M-1.7B-820.0M--
 
 
 
 
Net Proceeds Stock Sale60.0M114.0M111.0M--
 
 
 
 
Common Preferred Redeemed-125.0M0.000.00--
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing----------
Other Uses - Financing85.0M222.0M127.0M--
 
 
 
 
Net Cash Flow - Financing-150.0M1.3B-206.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.0M-4.0M-2.0M--
 
 
 
 
 
Net Change In Cash374.0M-264.0M-121.0M0.00